C11H22N2O2
214.3 g/mol
Pharmaceutical IntermediateDanger
Tert-butyl (2R)-2-(2-aminoethyl)pyrrolidine-1-carboxylate
CAS550378-07-9
Category
Pharmaceutical Intermediate
Compound Class
Amine
Primary Use
Pharmaceutical Intermediate
This compound is a chiral pyrrolidine derivative featuring a tert-butyl carbamate protecting group and a terminal amine. It is primarily utilized as a pharmaceutical intermediate in the synthesis of more complex active molecules.
pharmaceutical intermediate
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 550378-07-9
Related Compounds
SimilarStructure SimilarSimilarity 0.78
(S)-1-N-Boc-2-(aminomethyl)pyrrolidine
CAS119020-01-8
pharmaceutical intermediate
SimilarStructure SimilarSimilarity 0.78
(R)-2-(Aminomethyl)-1-N-Boc-pyyrolidine
CAS259537-92-3
pharmaceutical intermediate
ReferenceSame Category
(S)-1-Cbz-3-Aminopyrrolidine hydrochloride
CAS550378-39-7
pharmaceutical intermediate
ReferenceSame Category
2-Bromo-N-[4-chloro-2-(2-chlorobenzoyl)phenyl]acetamide
CAS5504-92-7
pharmaceutical intermediate
ReferenceSame Category
6-Chloro-7-azaindole
CAS55052-27-2
pharmaceutical intermediate
ReferenceSame Category
2,3,5-Tri-O-benzyl-D-ribonolactone
CAS55094-52-5
pharmaceutical intermediate
Referencestereoisomer of
Tert-Butyl (2S)-2-(2-aminoethyl)-1-pyrrolidinecarboxylate
CAS239483-09-1
pharmaceutical intermediate
Referencestereoisomer of
2-(Aminoethyl)-1-N-Boc-pyrrolidine
CAS370069-29-7
pharmaceutical intermediate
Safety Reference
Danger
H302Harmful if swallowed
H314Causes severe skin burns and eye damage
H315Causes skin irritation
H319Causes serious eye irritation
H335May cause respiratory irritation
Identifiers
IUPAC Name
tert-butyl (2R)-2-(2-aminoethyl)pyrrolidine-1-carboxylate
InChIKey
VCYKQOGWPICUKV-SECBINFHSA-N
SMILES
CC(C)(C)OC(=O)N1CCC[C@@H]1CCN
Synonyms (7)
—